Literature DB >> 31312029

Relationship of telomere length in colorectal cancer patients with cancer phenotype and patient prognosis.

Michal Kroupa1,2, Sivarama Krishna Rachakonda3, Vaclav Liska4, Nalini Srinivas3, Marketa Urbanova5,6, Katerina Jiraskova5,6, Michaela Schneiderova7, Ondrej Vycital4, Veronika Vymetalkova5,4,6, Ludmila Vodickova5,4,6, Rajiv Kumar3, Pavel Vodicka8,9,10.   

Abstract

BACKGROUND: Telomeres, repetitive DNA capping ends of eukaryotic chromosomes, are important in the maintenance of genomic integrity. Perturbed telomeres are common features of many human malignancies, including colorectal cancer.
METHODS: Telomere length (TL), measured by a Monochrome Multiplex Real-Time qPCR, was investigated in tumour tissues, adjacent mucosa, and blood from patients with colorectal cancer with different clinicopathological features and its impact on patient survival. TL was also measured in a limited number of liver metastases, non-cancerous liver tissues or corresponding tissues from the same patients.
RESULTS: TL in tumour tissues was shorter than in the adjacent mucosa (P < 0.0001). Shorter TL was observed in tumours with lower stage than in those with advanced stages (P = 0.001). TL was shorter in tumours at the proximal than at the distal sites of the colon (P < 0.0001). Shorter TL was also associated with microsatellite instability (P = 0.001) and mucinous tumour histology (P < 0.0001). Patients with a smaller TL ratio between tumour tissues and the adjacent mucosa were associated with increased overall survival (P = 0.022). Metastasised tumours had shorter telomeres than the adjacent non-cancerous liver tissues (P = 0.0005).
CONCLUSIONS: Overall, the results demonstrate differences in TL between tumours and the adjacent mucosa, between tumours located at different sites and association with patient survival.

Entities:  

Mesh:

Year:  2019        PMID: 31312029      PMCID: PMC6738117          DOI: 10.1038/s41416-019-0525-3

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Relative Telomere Length Change in Colorectal Carcinoma and Its Association with Tumor Characteristics, Gene Expression and Microsatellite Instability.

Authors:  Muhammad G Kibriya; Maruf Raza; Mohammed Kamal; Zahidul Haq; Rupash Paul; Andrew Mareczko; Brandon L Pierce; Habibul Ahsan; Farzana Jasmine
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

2.  Association of circulating leukocyte telomere length with survival in patients with colorectal cancer.

Authors:  Svenja Pauleck; Biljana Gigic; Richard M Cawthon; Jennifer Ose; Anita R Peoples; Christy A Warby; Jennifer A Sinnott; Tengda Lin; Juergen Boehm; Petra Schrotz-King; Christopher I Li; David Shibata; Erin M Siegel; Jane C Figueiredo; Adetunji T Toriola; Martin Schneider; Alexis B Ulrich; Albrecht Hoffmeister; Cornelia M Ulrich; Sheetal Hardikar
Journal:  J Geriatr Oncol       Date:  2022-01-05       Impact factor: 3.929

Review 3.  Colorectal Adenomas-Genetics and Searching for New Molecular Screening Biomarkers.

Authors:  Anna Siskova; Klara Cervena; Jan Kral; Tomas Hucl; Pavel Vodicka; Veronika Vymetalkova
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

4.  Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.

Authors:  Tomas Goncalves; Georgia Zoumpoulidou; Carlos Alvarez-Mendoza; Caterina Mancusi; Laura C Collopy; Sandra J Strauss; Sibylle Mittnacht; Kazunori Tomita
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-07

5.  Clinicopathological Characteristics of TZAP Expression in Colorectal Cancers.

Authors:  Soo-Jung Jung; Yu-Ri Seo; Won-Jin Park; Yu-Ran Heo; Yun-Han Lee; Shin Kim; Jae-Ho Lee
Journal:  Onco Targets Ther       Date:  2020-12-17       Impact factor: 4.147

6.  Telomerase (hTERT) Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia.

Authors:  Beatriz Maria Dias Nogueira; Laudreísa da Costa Pantoja; Emerson Lucena da Silva; Fernando Augusto Rodrigues Mello Júnior; Eliel Barbosa Teixeira; Alayde Vieira Wanderley; Jersey Heitor da Silva Maués; Manoel Odorico de Moraes Filho; Maria Elisabete Amaral de Moraes; Raquel Carvalho Montenegro; André Salim Khayat; Caroline Aquino Moreira-Nunes
Journal:  Genes (Basel)       Date:  2021-10-17       Impact factor: 4.096

7.  Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition.

Authors:  Jiri Jungwirth; Marketa Urbanova; Arnoud Boot; Petr Hosek; Petra Bendova; Anna Siskova; Jiri Svec; Milan Kment; Daniela Tumova; Sandra Summerova; Zdenek Benes; Tomas Buchler; Pavel Kohout; Tomas Hucl; Radoslav Matej; Ludmila Vodickova; Tom van Wezel; Pavel Vodicka; Veronika Vymetalkova
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.996

Review 8.  Telomerase in Cancer: Function, Regulation, and Clinical Translation.

Authors:  Nathaniel J Robinson; William P Schiemann
Journal:  Cancers (Basel)       Date:  2022-02-05       Impact factor: 6.639

9.  TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.

Authors:  Roberto Dinami; Manuela Porru; Carla Azzurra Amoreo; Isabella Sperduti; Marcella Mottolese; Simonetta Buglioni; Daniele Marinelli; Marcello Maugeri-Saccà; Andrea Sacconi; Giovanni Blandino; Carlo Leonetti; Giuliana Di Rocco; Alessandra Verdina; Francesca Spinella; Francesco Fiorentino; Gennaro Ciliberto; Annamaria Biroccio; Pasquale Zizza
Journal:  J Exp Clin Cancer Res       Date:  2020-06-15

10.  Telomere in colorectal cancer associated with distant metastases and predicted a poor prognosis.

Authors:  Xiaorong Ye; Jianjiong Li; Chenjun Song; Wenbin Chen
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.